Novel kynureninase inhibitor KS79356 slows triple-negative breast cancer progression
Researchers at King Khalid University have identified a small molecule, KS79356, that potently blocks the growth, invasion, and migration of ...
Researchers at King Khalid University have identified a small molecule, KS79356, that potently blocks the growth, invasion, and migration of ...
Arginine vasopressin, a peptide hormone better known for regulating water balance in the body, appears to help kill triple-negative breast ...
In a development that could reshape how experimental cancer drugs are vetted before they ever reach a patient, researchers have ...
Triple-negative breast cancer (TNBC) has earned its reputation as one of oncology’s most formidable challenges because it removes the molecular ...
In the relentless battle against triple-negative breast cancer (TNBC), a particularly aggressive and difficult-to-treat breast cancer subtype, a novel therapeutic ...
A novel experimental drug known as DH20931 has emerged as a promising candidate in the battle against triple-negative breast cancer ...
A groundbreaking study recently published in the distinguished journal Current Molecular Pharmacology brings to light a promising new avenue for ...
A groundbreaking preclinical study has introduced a promising paradigm in the fight against triple-negative breast cancer (TNBC), a notoriously aggressive ...
A groundbreaking study recently published in the prestigious journal Acta Pharmaceutica Sinica B has unveiled a promising new therapeutic candidate, ...
In a groundbreaking study, researchers have harnessed the power of multi-omics profiling to delve deep into the molecular complexities of ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine